BusinessTesaro Announces Presentations of Abstracts at the 2017 American Society of Clinical Oncology (ASCO) Annual MeetingBy Nasdaq OMXMay 25, 2017, 8:19 PM UTC
BusinessCrown Bioscience Announces Record Breaking Growth With First 2017 Quarter ResultsBy Nasdaq OMXMay 19, 2017, 11:57 AM UTC
BusinessCrown Bioscience Announces Record Breaking Growth With First 2017 Quarter ResultsBy Nasdaq OMXMay 19, 2017, 11:57 AM UTC
BusinessCrown Bioscience Announces Collaboration to Develop Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) AntibodyBy Nasdaq OMXMay 8, 2017, 2:04 PM UTC
BusinessCORRECTING and REPLACING -- Merus Announces Fourth Quarter and Full Year 2016 Financial Results and Corporate DevelopmentsBy Nasdaq OMXMay 3, 2017, 8:08 PM UTC
BusinessCORRECTING and REPLACING -- Merus Announces Fourth Quarter and Full Year 2016 Financial Results and Corporate DevelopmentsBy Nasdaq OMXMay 3, 2017, 8:08 PM UTC
BusinessTESARO Announces Submission of Investigational New Drug Application for Anti-LAG Antibody TSR-033 to the U.S. FDABy Nasdaq OMXMay 1, 2017, 12:32 PM UTC
BusinessTESARO Announces Submission of Investigational New Drug Application for Anti-LAG Antibody TSR-033 to the U.S. FDABy Nasdaq OMXMay 1, 2017, 12:32 PM UTC
